Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration

Lei Huang,Zhuorun Song,Jiayi Wang,Mengxuan Bian,Jiapeng Zou,Yanpei Zou,Jun Ge,Shunyi Lu

DOI: https://doi.org/10.1515/biol-2022-0854

2024-04-19

Open Life Sciences

Abstract:Large segmental bone defects are commonly operated with autologous bone grafting, which has limited bone sources and poses additional surgical risks. In this study, we fabricated poly(lactide- co -glycolic acid) (PLGA)/β-tricalcium phosphate (β-TCP) composite membranes by electrostatic spinning and further promoted osteogenesis by regulating the release of β-TCP in the hope of replacing autologous bone grafts in the clinical practice. The addition of β-TCP improved the mechanical strength of PLGA by 2.55 times. Moreover, β-TCP could accelerate the degradation of PLGA and neutralize the negative effects of acidification of the microenvironment caused by PLGA degradation. In vitro experiments revealed that PLGA/TCP10 membranes are biocompatible and the released β-TCP can modulate the activity of osteoblasts by enhancing the calcium ions concentration in the damaged area and regulating the pH of the local microenvironment. Simultaneously, an increase in β-TCP can moderate the lactate content of the local microenvironment, synergistically enhancing osteogenesis by promoting the tube-forming effect of human umbilical vein endothelial cells. Therefore, it is potential to utilize PLGA/TCP bioactive membranes to modulate the microenvironment at the site of bone defects to promote bone regeneration.

biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: in view of the problems of limited bone sources and increased surgical risks in autologous bone grafting for the repair of large - segment bone defects, the researchers developed a bioactive membrane composed of polylactic - co - glycolic acid (PLGA) and beta - tricalcium phosphate (β - TCP), which was prepared by electrospinning technology and promotes the differentiation of osteoblasts by regulating the release of β - TCP, with the expectation of replacing autologous bone grafting in clinical practice for bone regeneration treatment.

Specifically, the main research objectives include:
1. **Preparation of PLGA/β - TCP composite membrane**: Prepare PLGA composite membranes with different concentrations of β - TCP by electrospinning technology.
2. **Evaluation of the mechanical and thermal properties of the composite membrane**: Evaluate the mechanical properties and thermal stability of the composite membrane by methods such as tensile test, differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA).
3. **Study of the influence of the composite membrane on osteoblast differentiation**: Through in vitro experiments, evaluate the influence of the composite membrane extract on the proliferation, adhesion and osteogenic differentiation ability of bone marrow mesenchymal stem cells (BMSCs).
4. **Study of the influence of the composite membrane on angiogenesis**: Through in vitro experiments, evaluate the influence of the composite membrane extract on the tube - forming ability and invasive ability of human umbilical vein endothelial cells (HUVECs).

These research objectives aim to verify whether the PLGA/β - TCP composite membrane can effectively promote bone regeneration, thereby providing a new alternative for the clinical treatment of bone defects.